不同大小的人类αA-晶同质体的表征和对Asp151同质化的影响
Jiayue Sun1, Toshiya Matsubara2, Tamaki Koide3
1Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto, Japan.
PloS one
|July 11, 2024
概括
阿尔法A-晶体素的自发变化,如Asp151的异构化,有助于白内障. 这项研究表明,这些变化取决于蛋白质大小,而体外结果与体外观察结果不同.
科学领域:
- 生物化学 生物化学
- 蛋白质化学 蛋白质化学
- 眼科医生 眼科 眼科
背景情况:
- 晶体中的酸盐残留物修饰,特别是αA-晶体中的Asp151,导致蛋白质不稳定性和不溶性.
- 这些修饰,包括异体化和种族化,都与老年白内障形成有关.
- 驱动自发阿斯巴酸盐修饰的精确机制在实验上仍然未被阐明.
研究的目的:
- 调查αA-晶寡合体大小对Asp151.1.的自发异构化和种族化的影响.
- 描述具有不同寡合态的αA-晶体变体的结构,功能和稳定性差异,并在位置151处.
- 为了比较Asn151的体外除化与Asp151.1的体内修饰.
主要方法:
- 产生具有不同同类寡合体大小和/或151位的阿斯帕拉金蛋白的αA-晶体变异.
- 蛋白质结构的表征,疏水性,伴侣式功能和热稳定性.
- 通过Asn151脱化评估Asp151的异构化和种族化速率.
主要成果:
- 具有不同寡合体大小的αA-晶体变体显示了类似的二次结构,但具有不同的伴侣式功能.
- Asp151的异体化和种族化速度取决于alphaA-crystallin的寡合体大小.
- 在试验室中,除化主要产生L-β-Asp,与更复杂的体内修饰形成鲜明对比.
结论:
- 寡合体大小显著影响alphaA-crystallin的伴侣功能和Asp151异构化/种族化速率.
- 关于Asp151修饰的体外发现与体内观察不同,这表明生物系统的复杂性更大.
- 需要进一步的研究,才能充分理解在白内障发生过程中Asp151异构的体内机制.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Protein Folding
117.8K
Overview
117.8K
Protein and Protein Structure
79.4K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
79.4K
Polymer Classification: Crystallinity
2.8K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
2.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K


